ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Clomid for PCT, fertility or low T
Testosterone versus Clomid (clomiphene citrate) in managing symptoms of hypogonadism in men
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 72644" data-attributes="member: 3"><p><span style="font-family: 'Arial'">I could not see clomid dosages used. </span></p><p></p><p></p><p><span style="font-family: 'Arial'">This makes a big difference, as we now no too much zuclomiphene causes inverse effects. According to Dr Saya, this does not seem to happen in the low dose patients they see, which appears to be consistent with other doctors now using lower dose clomid.</span></p><p></p><p></p><p><span style="font-family: 'Arial'">Too bad enclomiphene is being held up, at least last I heard. This is an important tool for diagnosing younger men and/or boosting borderline TT levels that don't warrant full replacement. </span></p><p></p><p></p><p><span style="font-family: 'Arial'">Either way, nothing works as good as testosterone supplementation since you get a guaranteed bell curve of androgens after administration.</span></p><p></p><p><span style="font-family: 'Arial'">_______________________________________</span></p><p></p><p><span style="font-family: 'Arial'"><strong>Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men</strong></span></p><p></p><p><span style="font-family: 'Arial'">Pranav Dadhich1, Ranjith Ramasamy2, Jason Scovell1, Nathan Wilken1, Larry Lipshultz1</span></p><p><span style="font-family: 'Arial'">1 Scott Department of Urology, Baylor College of Medicine, Houston, USA</span></p><p><span style="font-family: 'Arial'">2 Department of Urology, University of Miami Miller School of Medicine, Miami, Florida, USA</span></p><p></p><p></p><p></p><p><span style="font-family: 'Arial'">Introduction: Both clomiphene citrate (CC) and testosterone supplementation therapy (TST) are effective treatments for men with hypogonadism. We sought to compare changes in symptoms and treatment efficacy in hypogonadal men before and after receiving CC and TST. Patients and Methods: 52 men who received TST and 23 men who received CC for symptomatic hypogonadism were prospectively followed for change in hormone levels and symptoms after treatment. These men were also compared to eugonadal men who were not on CC or TST during the same period. Comparisons were made between baseline and posttreatment hormone levels and symptoms. Symptoms were evaluated using the androgen deficiency in aging male (ADAM) and quantitative ADAM (qADAM) questionnaires. Results: Serum total testosterone increased from pretreatment levels in all men (P < 0.05), regardless of therapy type (TST: 281&#8211;541 ng/dL, CC: 235.5&#8211;438 ng/dL). Men taking TST reported fewer ADAM symptoms after treatment (5&#8211;2,P < 0.05). Similarly, men taking CC reported fewer ADAM symptoms after treatment (3.5&#8211;1.5,P < 0.05). Conversely, eugonadal men had similar T levels (352 vs. 364 ng/dL) and hypogonadal symptoms (1.5 vs. 1.4) before and after follow-up. When we evaluated individual symptoms, men treated with TST showed significant increases in qADAM scores in libido, erectile function, and sports performance. However, among the men who received CC, qADAM subscore for libido was lower following treatment (3.75&#8211;3.2,P = 0.04),<strong> indicating that CC could have an adverse effect on libido in hypogonadal men.</strong> Conclusions: <strong>Both TST and CC are effective medications in treating hypogonadism; however, our study indicates that TST is more effective in raising serum testosterone levels and improving hypogonadal symptoms. CC remains a viable treatment modality for hypogonadal men but its adverse effect on libido warrant further study.</strong></span></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 72644, member: 3"] [FONT=Arial]I could not see clomid dosages used. [/FONT] [FONT=Arial]This makes a big difference, as we now no too much zuclomiphene causes inverse effects. According to Dr Saya, this does not seem to happen in the low dose patients they see, which appears to be consistent with other doctors now using lower dose clomid.[/FONT] [FONT=Arial]Too bad enclomiphene is being held up, at least last I heard. This is an important tool for diagnosing younger men and/or boosting borderline TT levels that don't warrant full replacement. [/FONT] [FONT=Arial]Either way, nothing works as good as testosterone supplementation since you get a guaranteed bell curve of androgens after administration.[/FONT] [FONT=Arial]_______________________________________[/FONT] [FONT=Arial][B]Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men[/B][/FONT] [FONT=Arial]Pranav Dadhich1, Ranjith Ramasamy2, Jason Scovell1, Nathan Wilken1, Larry Lipshultz1 1 Scott Department of Urology, Baylor College of Medicine, Houston, USA 2 Department of Urology, University of Miami Miller School of Medicine, Miami, Florida, USA[/FONT] [FONT=Arial]Introduction: Both clomiphene citrate (CC) and testosterone supplementation therapy (TST) are effective treatments for men with hypogonadism. We sought to compare changes in symptoms and treatment efficacy in hypogonadal men before and after receiving CC and TST. Patients and Methods: 52 men who received TST and 23 men who received CC for symptomatic hypogonadism were prospectively followed for change in hormone levels and symptoms after treatment. These men were also compared to eugonadal men who were not on CC or TST during the same period. Comparisons were made between baseline and posttreatment hormone levels and symptoms. Symptoms were evaluated using the androgen deficiency in aging male (ADAM) and quantitative ADAM (qADAM) questionnaires. Results: Serum total testosterone increased from pretreatment levels in all men (P < 0.05), regardless of therapy type (TST: 281–541 ng/dL, CC: 235.5–438 ng/dL). Men taking TST reported fewer ADAM symptoms after treatment (5–2,P < 0.05). Similarly, men taking CC reported fewer ADAM symptoms after treatment (3.5–1.5,P < 0.05). Conversely, eugonadal men had similar T levels (352 vs. 364 ng/dL) and hypogonadal symptoms (1.5 vs. 1.4) before and after follow-up. When we evaluated individual symptoms, men treated with TST showed significant increases in qADAM scores in libido, erectile function, and sports performance. However, among the men who received CC, qADAM subscore for libido was lower following treatment (3.75–3.2,P = 0.04),[B] indicating that CC could have an adverse effect on libido in hypogonadal men.[/B] Conclusions: [B]Both TST and CC are effective medications in treating hypogonadism; however, our study indicates that TST is more effective in raising serum testosterone levels and improving hypogonadal symptoms. CC remains a viable treatment modality for hypogonadal men but its adverse effect on libido warrant further study.[/B][/FONT] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Clomid for PCT, fertility or low T
Testosterone versus Clomid (clomiphene citrate) in managing symptoms of hypogonadism in men
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top